Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Kranaster

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Neuroimage|April 30, 2013
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophreniaJenny Ceccarini, Marc De Hert, Ruud Van Winkel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 24, 2016
Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot studyLaura Kranaster, Suna Su Aksay, Jan Malte Bumb, et al.
Schizophrenia Research|June 15, 2007
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis useF Markus Leweke, Andrea Giuffrida, Dagmar Koethe, et al.
Proteomics|December 25, 2010
Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survivalMarlis Herberth, Dagmar Koethe, Yishai Levin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 25, 2014
Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processingDavide Rivolta, Nazareth P Castellanos, Cerisa Stawowsky, et al.
Translational Psychiatry|September 12, 2023
Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depressionLalit Kaurani, Matthias Besse, Isabel Methfessel, et al.
Clinical Schizophrenia & Related Psychoses|February 12, 2013
Identification of a molecular profile associated with immune status in first-onset schizophrenia patientsMarlis Herberth, Hassan Rahmoune, Emanuel Schwarz, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 4, 2018
Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapyJerome C Foo, Fabian Streit, Josef Frank, et al.
Plos One|August 23, 2007
CSF metabolic and proteomic profiles in patients prodromal for psychosisJeffrey T-J Huang, F Markus Leweke, Tsz M Tsang, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 25, 2019
The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluidLaura Kranaster, Carolin Hoyer, Sonani Mindt, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Neuroimage|April 30, 2013
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophreniaJenny Ceccarini, Marc De Hert, Ruud Van Winkel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 24, 2016
Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot studyLaura Kranaster, Suna Su Aksay, Jan Malte Bumb, et al.
Schizophrenia Research|June 15, 2007
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis useF Markus Leweke, Andrea Giuffrida, Dagmar Koethe, et al.
Proteomics|December 25, 2010
Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survivalMarlis Herberth, Dagmar Koethe, Yishai Levin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 25, 2014
Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processingDavide Rivolta, Nazareth P Castellanos, Cerisa Stawowsky, et al.
Translational Psychiatry|September 12, 2023
Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depressionLalit Kaurani, Matthias Besse, Isabel Methfessel, et al.
Clinical Schizophrenia & Related Psychoses|February 12, 2013
Identification of a molecular profile associated with immune status in first-onset schizophrenia patientsMarlis Herberth, Hassan Rahmoune, Emanuel Schwarz, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 4, 2018
Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapyJerome C Foo, Fabian Streit, Josef Frank, et al.
Plos One|August 23, 2007
CSF metabolic and proteomic profiles in patients prodromal for psychosisJeffrey T-J Huang, F Markus Leweke, Tsz M Tsang, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 25, 2019
The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluidLaura Kranaster, Carolin Hoyer, Sonani Mindt, et al.
Pageof 6